Metraipolis › archive › dc_eab9c8a84353
Single-dose pharmacokinetics, tolerability, and physiologically based pharmacokinetic modeling of Fazamorexant in Chinese patients with hepatic impairment and… — Europe PMC PMID:42110531
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42110531
- DOI
- 10.3389/fphar.2026.1814155
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T06:16:27.483Z
- SHA-256 of the archived text
062e81a6b69ecd84c4bec0bf32e3ebfdd9f70e7174325e4f6b1b23bcffe3b960- Stable URL of this page
https://metraipolis.com/documento/dc_eab9c8a84353
How to cite
Single-dose pharmacokinetics, tolerability, and physiologically based pharmacokinetic modeling of Fazamorexant in Chinese patients with hepatic impairment and… — Europe PMC PMID:42110531 — Europe PMC (en), https://europepmc.org/article/MED/42110531 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eab9c8a84353 (Metraipolis archive dc_eab9c8a84353, sha256 062e81a6b69ecd84c4bec0bf32e3ebfdd9f70e7174325e4f6b1b23bcffe3b960)
BibTeX
@misc{dceab9c8a84353,
title = {Single-dose pharmacokinetics, tolerability, and physiologically based pharmacokinetic modeling of Fazamorexant in Chinese patients with hepatic impairment and… — Europe PMC PMID:42110531},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42110531},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eab9c8a84353; sha256 062e81a6b69ecd84c4bec0bf32e3ebfdd9f70e7174325e4f6b1b23bcffe3b960},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42110531. Agents can read the archived copy with the MCP tool read_document.